Stempoint Capital »

Astrazeneca Plc Ord shares owned by Stempoint Capital

Quarter-by-quarter ownership of Astrazeneca Plc Ord (AZN) shares owned by Stempoint Capital from 13F filings

Historical chart of Stempoint Capital investment in Astrazeneca Plc Ord

Tip: Access up to 7 years of quarterly data

All positions including Astrazeneca Plc Ord held by Stempoint Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Astrazeneca Plc Ord by Stempoint Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $180k 25k 7.20

More positions owned by Stempoint Capital

Tango Therapeutics (TNGX)
Abivax Sa Sponsored Ads (ABVX)
Revolution Medicines (RVMD)
Erasca (ERAS)
Biohaven (BHVN)
Tyra Biosciences (TYRA)
Dianthus Therapeutics (DNTH)
Enliven Therapeutics (ELVN)
Mineralys Therapeutics (MLYS)
Roivant Sciences SHS (ROIV)
Surrozen Com New (SRZN)
Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA)
Scholar Rock Hldg Corp (SRRK)
Alkermes SHS (ALKS)
First Tracks Biotherapeutics Ord Shs (TRAX)

View all positions for Stempoint Capital

Top funds holding Astrazeneca Plc Ord

Investor AB
Vanguard Capital Management
Capital Research and Management Company - Division 3
Norges Bank Investment Management
FMR
Wellington Management Company
Capital World Investors
Legal & General Group
T. Rowe Price Associates
Jpmorgan Chase & Co
Vanguard Asset Management
PRIMECAP Management Company
Bank of America Corporation
Franklin Resources
Amundi

View all funds holding Astrazeneca Plc Ord